Clinical Trial Update: A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytial Virus [Phase 2]

View source ↗

Summary

Phase 2a trial evaluating orally administered ALS-008176 in adults hospitalized with respiratory syncytial virus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infections

Drugs mentioned

• ALS-008176

Snippet

Sponsor: Alios Biopharma Inc. | Conditions: Respiratory Syncytial Virus Infections | Phase 2 | Status: COMPLETED